ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 12 filers reported holding ACASTI PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $28,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 684,600 | $527,000 | 0.31% |
| Perceptive Advisors | 206,677 | $117,000 | 0.00% |
| Virtu Financial LLC | 41,066 | $23,000 | 0.00% |
| INTACT INVESTMENT MANAGEMENT INC. | 48,990 | $37,000 | 0.00% |
| TORONTO DOMINION BANK | 100 | $0 | 0.00% |
| MORGAN STANLEY | 40,000 | $23,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 154,439 | $88,000 | 0.00% |
| Citadel Advisors | 32,648 | $19,000 | 0.00% |
| BREWIN DOLPHIN LTD | 30 | $17 | 0.00% |
| Renaissance Technologies | 18,600 | $11,000 | 0.00% |